Olprezide (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olprezide, is an angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olprezide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olprezide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olprezide is an antihypertensive medication that acts on the renin‑angiotensin system to lower blood pressure.

- Hypertension: helps lower systolic and diastolic blood pressure in adults. - Heart failure: used as part of combination therapy to improve fluid balance and reduce cardiac workload. - Diabetic nephropathy: contributes to renal protection by controlling blood pressure in patients with type 2 diabetes.

Olprezide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Severe electrolyte imbalance - Hepatic dysfunction

Before starting Olprezide, patients should be evaluated for several safety considerations.

- Renal function: assess baseline kidney function and monitor periodically. - Electrolytes: check serum potassium and sodium levels before initiation and during therapy. - Pregnancy: avoid use during pregnancy, especially the second and third trimesters. - Concomitant drugs: review other antihypertensives or potassium‑sparing agents. - Elderly patients: start at lower doses and monitor for orthostatic symptoms. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olprezide can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren: combined use with an ARB may increase risk of renal impairment and hyperkalemia. - Lithium: concurrent use can raise lithium levels, risking toxicity. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect and impair renal function. - ACE inhibitors: combined use can increase risk of hypotension and kidney injury. - Antidiabetic drugs: may require dose adjustment due to enhanced glucose‑lowering effect.